None listed
Conditions
Interventions
None listed
Sponsors
Bharat Biotech International Limited BBIL
Clinical Research Network India CRO
Eligibility
Inclusion criteria
Inclusion criteria: Families which have children in the age group 12 to 18 years
Exclusion criteria
Exclusion criteria: Children with chronic disorders Unable to comprehend the questions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number and frequency (infection rate) of symptomatic COVID-19 infection among family members of fully vaccinated, partially vaccinated, and unvaccinated children from both rural and urban areas (separately and combined). Severity of COVID-19 infection in children from fully vaccinated, partially vaccinated, and unvaccinated cohort observed from both rural and urban areas (separately and combined). Timepoint: The subject and their families will be followed up for every 15 days for a period of one year as per the pre-decided schedule | — |
Secondary
| Measure | Time frame |
|---|---|
| Number and frequency (infection rate) of symptomatic COVID-19 infection among family members of fully vaccinated, partially vaccinated, and unvaccinated children from both rural and urban areas (separately and combined). Severity of COVID-19 infection in children from fully vaccinated, partially vaccinated, and unvaccinated cohort observed from both rural and urban areas (separately and combined). Number and frequency (infection rate) of reinfection in children from fully vaccinated, partially vaccinated, and unvaccinated cohort from both rural and urban areas (separately and combined).Timepoint: The subject and their families will be followed up for every 15 days for a period of one year as per the pre-decided schedule | — |
Countries
India
Contacts
Public ContactDr Nidhi Singh
Bharat Biotech International Ltd
Outcome results
None listed